Quarterly report pursuant to Section 13 or 15(d)

Business (Details)

v3.8.0.1
Business (Details)
1 Months Ended 3 Months Ended
Feb. 16, 2018
USD ($)
Aug. 31, 2017
USD ($)
Mar. 31, 2018
USD ($)
product
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Number of products in development | product     3    
License and other revenue   $ 25,000,000      
Escrowed cash receivable   $ 3,750,000 $ 3,754,455   $ 3,752,390
Escrow period   12 months      
Potential future regulatory milestone payment   $ 20,000,000      
Subsequent Event [Line Items]          
Net loss     (3,882,847) $ (1,960,638)  
Cash flows from operations     (280,423) (2,236,465)  
Accumulated deficit     (62,048,107)   (58,165,260)
Cash and cash equivalents     $ 2,523,927 $ 3,001,553 $ 2,472,187
Avadel          
Subsequent Event [Line Items]          
Long-term debt acquired $ 15,272,303        
Product royalty 15.00%